ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

IOM Report Lists Cancer CER Priorities

July 3, 2009

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

NCI FY94 Budget By Mechanism Under House, Senate Mark

September 24, 1993

NCI Considering Master Agreements For Cancer Centers

August 2, 1991

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

News Analysis: Legislation on Drug Shortage Crisis Moves Toward Passage on Capitol Hill

June 22, 2012